Literature DB >> 21748606

Risk of acute exacerbation of interstitial pneumonia after pulmonary resection for lung cancer in patients with idiopathic pulmonary fibrosis based on preoperative high-resolution computed tomography.

Hidemi Suzuki1, Yasuo Sekine, Shigetoshi Yoshida, Makoto Suzuki, Kiyoshi Shibuya, Yoko Yonemori, Kenzo Hiroshima, Yukio Nakatani, Satoko Mizuno, Yuichi Takiguchi, Ichiro Yoshino.   

Abstract

PURPOSE: In patients with lung cancer accompanied by idiopathic pulmonary fibrosis (IPF), acute exacerbation of the IPF often occurs after pulmonary resection; however, few studies have been done to identify its preexisting risk factors.
METHODS: We analyzed the high-resolution computed tomography (HRCT) findings of IPF to identify the radiological characteristics of IPF susceptible to acute exacerbation after lung cancer surgery. We reviewed retrospectively 28 lung cancer patients with IPF who underwent pulmonary resection. Clinical data, respiratory function, HRCT findings, and historical features were compared between the acute exacerbation (n = 9) and nonexacerbation (n = 19) groups. The classification of radiological findings of IPF on HRCT was done using a scoring system of seven factors related to the interstitial shadow, including fibrosis, ground-glass opacity, and low-attenuation area.
RESULTS: There were no significant differences in clinical background, respiratory function, composite physiologic index, or pathological features between the groups; however, the degree of fibrosis on preoperative HRCT was significantly higher in the exacerbation group (P < 0.003). The fibrosis score was higher on the opposite side to the lung cancer in the exacerbation group (P < 0.05).
CONCLUSION: Although it is difficult to predict postoperative acute IPF exacerbation, the degree and laterality of co-existing fibrosis seem to be predictors.

Entities:  

Mesh:

Year:  2011        PMID: 21748606     DOI: 10.1007/s00595-010-4384-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  30 in total

1.  RELATIONSHIP OF INTERSTITIAL PNEUMONIA HONEYCOMBING AND ATYPICAL EPITHELIAL PROLIFERATION TO CANCER OF THE LUNG.

Authors:  E C MEYER; A A LIEBOW
Journal:  Cancer       Date:  1965-03       Impact factor: 6.860

2.  Increased intensity of lung infiltrates at the side of lung cancer in patients with lung cancer associated with pulmonary fibrosis.

Authors:  J Fujita; I Yamadori; H Namihira; I Suemitsu; S Bandoh; Y Fukunaga; S Hojo; Y Ueda; N Dobashi; K Dohmoto; J Takahara
Journal:  Lung Cancer       Date:  1999-12       Impact factor: 5.705

Review 3.  Acute exacerbation of idiopathic pulmonary fibrosis: a systematic review.

Authors:  Ritesh Agarwal; Surinder K Jindal
Journal:  Eur J Intern Med       Date:  2008-01-16       Impact factor: 4.487

4.  Patterns of surgical care of lung cancer patients.

Authors:  Alex G Little; Valerie W Rusch; James A Bonner; Laurie E Gaspar; Mark R Green; W Richard Webb; Andrew K Stewart
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

5.  Carcinoma and diffuse interstitial fibrosis of lung.

Authors:  A E Fraire; S D Greenberg
Journal:  Cancer       Date:  1973-05       Impact factor: 6.860

6.  The influence of hospital volume on survival after resection for lung cancer.

Authors:  P B Bach; L D Cramer; D Schrag; R J Downey; S E Gelfand; C B Begg
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

7.  Interstitial shadow on chest CT is associated with the onset of interstitial lung disease caused by chemotherapeutic drugs.

Authors:  Seiji Niho; Koichi Goto; Kiyotaka Yoh; Young Hak Kim; Hironobu Ohmatsu; Kaoru Kubota; Nagahiro Saijo; Yutaka Nishiwaki
Journal:  Jpn J Clin Oncol       Date:  2006-05-15       Impact factor: 3.019

8.  Liver transplantation from a non-heart-beating donor after pulmonary failure: report of a case.

Authors:  Walid Faraj; Gabriele Marangoni; Faisal Dar; Deborah Mukherji; Nigel Heaton; Paolo Muiesan
Journal:  Surg Today       Date:  2009-09-27       Impact factor: 2.549

9.  Idiopathic diffuse interstitial pulmonary fibrosis (fibrosing alveolitis), atypical epithelial proliferation and lung cancer.

Authors:  R Haddad; D Massaro
Journal:  Am J Med       Date:  1968-08       Impact factor: 4.965

10.  Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends.

Authors:  Panagiota I Latsi; Roland M du Bois; Andrew G Nicholson; Thomas V Colby; Danai Bisirtzoglou; Ageliki Nikolakopoulou; Srihari Veeraraghavan; David M Hansell; Athol U Wells
Journal:  Am J Respir Crit Care Med       Date:  2003-06-05       Impact factor: 21.405

View more
  27 in total

Review 1.  Lung cancer and interstitial lung disease: a literature review.

Authors:  Jean-Marc Naccache; Quentin Gibiot; Isabelle Monnet; Martine Antoine; Marie Wislez; Christos Chouaid; Jacques Cadranel
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Proposal.

Authors:  Kerri Johannson; Harold R Collard
Journal:  Curr Respir Care Rep       Date:  2013-12

3.  Acute exacerbation of interstitial lung disease with lung cancer after surgery: evaluation with 2-[18]-fluoro-2-deoxy-D-glucose positron emission tomography.

Authors:  Tomohiro Maniwa; Masahiro Endo; Mitsuhiro Isaka; Kazuo Nakagawa; Yasuhisa Ohde; Takehiro Okumura; Haruhiko Kondo
Journal:  Surg Today       Date:  2013-09-05       Impact factor: 2.549

4.  The utility of ground-glass attenuation score for anticancer treatment-related acute exacerbation of interstitial lung disease among lung cancer patients with interstitial lung disease.

Authors:  Naoki Nishiyama; Takayuki Honda; Manabu Sema; Tatsuo Kawahara; Yasuto Jin; Ichiro Natsume; Tomoshige Chiaki; Takaaki Yamashita; Yoshikazu Tsukada; Reiko Taki; Yoshihiro Miyashita; Kazuhito Saito; Tomoya Tateishi; Hiroyuki Sakashita; Yasunari Miyazaki
Journal:  Int J Clin Oncol       Date:  2019-11-13       Impact factor: 3.402

5.  Distribution of interstitial pneumonia: a new radiological predictor of 90-day mortality after resection of lung cancer.

Authors:  Mariko Fukui; Kenji Suzuki; Shiaki Oh; Takeshi Matsunaga; Yoshikazu Miyasaka; Izumi Kawagoe; Kazuya Takamochi
Journal:  Surg Today       Date:  2015-03-05       Impact factor: 2.549

Review 6.  Exacerbations in idiopathic pulmonary fibrosis triggered by pulmonary and nonpulmonary surgery: a case series and comprehensive review of the literature.

Authors:  Abhijeet Ghatol; A Parker Ruhl; Sonye K Danoff
Journal:  Lung       Date:  2012-04-29       Impact factor: 2.584

7.  A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients.

Authors:  Toshihiko Sato; Haruhiko Kondo; Atsushi Watanabe; Jun Nakajima; Hiroshi Niwa; Hirotoshi Horio; Jiro Okami; Norihito Okumura; Kenji Sugio; Satoshi Teramukai; Kazuma Kishi; Masahito Ebina; Yukihiko Sugiyama; Takashi Kondo; Hiroshi Date
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-10-30

Review 8.  Perioperative management of hepatectomy in patients with interstitial pneumonia: a report of three cases and a literature review.

Authors:  Norio Kubo; Kenichiro Araki; Takahiro Yamanaka; Kouki Hoshino; Norihiro Ishii; Mariko Tsukagoshi; Takamichi Igarashi; Akira Watanabe; Keitaro Hirai; Fumiyoshi Saitoh; Hiroyuki Kuwano; Ken Shirabe
Journal:  Surg Today       Date:  2017-03-01       Impact factor: 2.549

9.  Outcomes of Older Patients with Pulmonary Fibrosis and Non-Small Cell Lung Cancer.

Authors:  Stacey-Ann Whittaker Brown; Maria Padilla; Grace Mhango; Emanuela Taioli; Charles Powell; Juan Wisnivesky
Journal:  Ann Am Thorac Soc       Date:  2019-08

10.  Accuracy and complications of percutaneous transthoracic needle lung biopsy for the diagnosis of malignancy in patients with idiopathic pulmonary fibrosis.

Authors:  Yoon Joo Shin; Gabin Yun; Sung Hyun Yoon; Hwayoung Song; Junghoon Kim; Jihang Kim; Jong Sun Park; Kyoung Won Lee; Kyung Hee Lee
Journal:  Eur Radiol       Date:  2021-05-18       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.